Bionano Genomics Cash from Operations (TTM) Insights

Bionano Genomics Inc (BNGO)

1.135 +0.02 (+2.25%) USD | NASDAQ | May 17, 16:00

1.135 0.00 (0.00%) After-Hours: 16:43

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	-120.90M
December 31, 2023	-125.18M
September 30, 2023	-129.92M
June 30, 2023	-133.10M
March 31, 2023	-124.74M
December 31, 2022	-124.82M
September 30, 2022	-115.92M
June 30, 2022	-106.43M
March 31, 2022	-90.52M
December 31, 2021	-71.93M
September 30, 2021	-58.41M
June 30, 2021	-49.39M
March 31, 2021	-44.19M

Date	Value
December 31, 2020	-38.31M
September 30, 2020	-35.59M
June 30, 2020	-31.91M
March 31, 2020	-31.01M
December 31, 2019	-29.53M
September 30, 2019	-24.24M
June 30, 2019	-23.06M
March 31, 2019	-19.71M
December 31, 2018	-19.94M
September 30, 2018	-18.66M
June 30, 2018	-18.22M
March 31, 2018	-20.24M
December 31, 2017	-20.82M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-133.10M

Minimum

Jun 2023

-23.06M

Maximum

Jun 2019

-75.45M

Average

-65.17M

Median

Cash from Operations (TTM) Benchmarks